Navigation Links
Study gives clues to how adrenal cancer forms
Date:6/4/2009

ANN ARBOR, Mich. At the ends of chromosome are special pieces of DNA called telomeres. Think of it as the little tip that caps off a shoelace. The telomeres send signals to the cells to let them know it's the end point, not a break that should be repaired.

Over time, as cells reproduce, the telomeres become shorter and eventually no longer do their job. The cells then have a higher risk of mutating into cancer.

But, a new study finds, if the telomere becomes dysfunctional at any point regardless of shortening it can trigger a cancer event. The study, by researchers at the University of Michigan Comprehensive Cancer Center, was done in mice generally prone to develop cancer. The mice that also had dysfunctional telomeres were particularly prone to develop the usually ultra-rare adrenocortical cancer. This is the first mouse model to specifically address this rare but lethal type of cancer.

"Usually when telomeres get short, they also seem to get deprotected. No one's been able to say if it's the shortening or the deprotection that causes cancer to arise. In this study, we were able to show that deprotection alone, even in the absence of a short telomere, is enough to trigger cancer. This may be a general mechanism of adrenal cancer as well as many other cancers in the body," says study author Gary Hammer, M.D., Ph.D., the Millie Schembechler Professor of Adrenal Cancer at the U-M Comprehensive Cancer Center.

Results of the study appear in the June issue of Cancer Cell.

The researchers also found that a protein called p53 usually prevents the cancer trigger. P53 is critical to the cell destruction process. When it's missing, cells replicate uncontrolled, the hallmark of cancer. In this study, the researchers eliminated p53 in the mice and found that the dysfunctional telomeres then tried to repair themselves. This led to breaks in the chromosome, causing scrambled genes and mutations.

"P53 mutat
'/>"/>

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Protein may be strongest indicator of rare lung disease, study shows
2. People who wear rose-colored glasses see more, University of Toronto study shows
3. 5 Spanish centers join a study for a new leukemia and lymphoma treatment technique
4. Natura Therapeutics and USF receive NIH grant to study green tea compound for Alzheimers
5. FDA to Study Ways to Be More Open With Public
6. Study further expands understanding of leptins role in brain neurocircuitry
7. NASA Selects Four Proposals to Study Space Radiation Risks
8. Study Results Show CAQH CORE Certification Dramatically Cuts Administrative Costs, Accelerates I.T. Adoption by Providers and Health Plans
9. Study: Benefit to women not enough to sway men to get HPV vaccine
10. New study shows people with mental health problems receive inadequate medical care
11. Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study gives clues to how adrenal cancer forms
Study gives clues to how adrenal cancer forms
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2
..., THURSDAY, Sept. 13 (HealthDay News) -- It,s unde...eone else,s used-up chewing gum. , But relief may ...wrap a non -stick, easy-to-remove version of chew...ts indicate that it degrades naturally in water, a...
...ation (NYSE: SYK ) announced today that it will p...September 25, 2007 - 4:30 p.m. Eastern Time UBS G... A simultaneous webcast of the Company,s presenta...chived for 30 days. Certain statements made in th...
...nc.,(NYSE: MYL ) today announced the appointment ...ce President and Chief Compliance Officer. Ms. La... she was,Director of Compliance for Latin America,...erca held executive and,senior counsel positions w...
...WASHINGTON, Sept. 14 - The successful,implementati...te of,Mississippi,s Medicaid program $1.2 million ...Government Health IT. The savings and increased qu...CMA) said today., "The state of Mississippi shoul...
...protective treatments , FRIDAY, Sept. 14 (HealthDa...chers found that a pill called dabigatran etexilat...noxaparin, in reducing the risk of blood clots aft...eived either oral DE at 220 milligrams daily, DE a...
...vivor, General,Colin Powell is doing his part to i...ce of prevention. In 2003, the former Secretary o...made a full recovery. Since that time, General Pow...arly detection is the best weapon we have against ...
Other Medicine News:Health News:Stryker to Present at Investor Conference 2Health News:Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer 2Health News:E-Prescribing Saving Mississippi Medicaid $1.2 Million Per Month 2Health News:Pill Equals Injection in Preventing Clots After Hip Replacement 2Health News:General Colin Powell Speaks Out for Prostate Cancer Prevention 2
(Date:12/4/2009)SAN DIEGO, Calif., Dec. 4 Suneva Medical, a privately-held aesthetic medical device company, today announced the appointment of Philip Ranker as Vice President and Chief Financial Officer. In this r
(Date:12/4/2009)TARRYTOWN, N.Y., Dec. 4 Bayer Diabetes Care today announced the three grand prize winners of Bayer,s "Express Your Simple Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the winn
(Date:12/4/2009)RARITAN, N.J., Dec. 4 Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Caltech scientists create robot surrogate for blind persons in testing visual prostheses 10414 1Caltech scientists create robot surrogate for blind persons in testing visual prostheses 10414 2Caltech scientists create robot surrogate for blind persons in testing visual prostheses 10414 3CDPHP Launches National Network and Three In One Plan and Expands Member Incentives 59754 1CDPHP Launches National Network and Three In One Plan and Expands Member Incentives 59754 2CDPHP Launches National Network and Three In One Plan and Expands Member Incentives 59754 3CDPHP Launches National Network and Three In One Plan and Expands Member Incentives 59754 4Drugs for Inflammatory Bowel Might Increase Cancer Risk 59751 1Drugs for Inflammatory Bowel Might Increase Cancer Risk 59751 2
...Pharmaceutical Company,Limited (Takeda) announced ...nter, Inc. submitted a New Drug Application (NDA) ...(FDA) for alogliptin (development code:,SYR-322), ...inhibitor under,investigation for the treatment of...Inc., alogliptin was designed to selectively inhib...
...ontinence Who Have Failed Alternative ...Jan. 3 Tengion, Inc., a clinical,stage regenerati...neo-organs and neo-vessels, announced today it is ... trial of its Neo-Bladder Augment derived from,a p...udy is being conducted,at five hospitals in 10 adu...
Other Medicine Technology:Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S. 2Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S. 3Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S. 4Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder 2Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder 3Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder 4
Broncho-Cath® Endobronchial Tube with CPAP System
...made of silicone rubber with a wire reinforced end... of silicone rubber, Silbronco is soft and less tr...the tube will not soften like PVC tubes, which mak...lbronco is also especially useful when a tumor lif...
Portex Pedia-Trake® Pediatric Emergency Cricothyrotomy Kit
Melker Emergency Cricothyrotomy Catheter Sets
Medicine Products: